Search for: "John Doe 1-40,000" Results 21 - 40 of 134
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
16 Nov 2014, 6:08 am by Lawrence B. Ebert
There are more than 40,000 paid speakers, about 1/3 of which are motivational.Author Jonathan Black on the impulse to improve. [read post]
5 Jul 2018, 9:01 pm by Jim Sedor
From the States and Municipalities: Florida: Where Does She Live? [read post]
9 Sep 2014, 10:29 am by John Tishler
All companies that are listed on NASDAQ will become subject to the All-Inclusive Annual Fee commencing on January 1, 2018. [read post]
12 Aug 2010, 6:56 am by Gritsforbreakfast
"An LVN does not have the ability to do that. [read post]
8 Mar 2024, 12:19 pm by Irene
“If it does stay down, I have been instructed not to pursue this matter further,” Boehm writes in the email. [read post]
6 Aug 2012, 9:35 am by CJLF Staff
His roommate and accomplice, John Matzke, confessed the murders to the police, implicating Cook. [read post]
25 Nov 2013, 3:42 pm by David Fraser
Marijuana privacy breach class action blog postThis afternoon, my firm filed a statement of claim in the Federal Court against Health Canada (John Doe v. [read post]
15 Apr 2022, 6:00 am by The Petrie-Flom Center Staff
One does not make the same regulations for a house cat as for a lion, unless one is equally ignorant of both. [read post]
28 Jun 2017, 2:02 pm by Matthew Kahn
” DMP performed the following services: 1. [read post]
30 Nov 2011, 4:35 am by Lawrence Higgins
Presenters include: Kent Erickson, Bryan Stanley, and John Garretson. [read post]
2 May 2012, 8:53 am by Joe Consumer
IOM concludes, “the FDA’s current approach to drug oversight in the postmarket setting is not sufficiently systematic and does not ensure that it assesses the benefits and risks of drugs consistently over the drug’s life cycle. [read post]
20 Jul 2012, 7:55 am by Kathryn Fenderson Scott
"And you have a sign in front of a crack house on 14th Street in Bradenton, does that mean you’re endorsing crackheads? [read post]
2 May 2012, 8:53 am by Joe Consumer
IOM concludes, “the FDA’s current approach to drug oversight in the postmarket setting is not sufficiently systematic and does not ensure that it assesses the benefits and risks of drugs consistently over the drug’s life cycle. [read post]